- Home
- AMPH
as of 12-11-2025 2:26pm EST
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | RANCHO CUCAMONGA |
| Market Cap: | 1.3B | IPO Year: | 2014 |
| Target Price: | $31.00 | AVG Volume (30 days): | 385.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.27 | EPS Growth: | -24.59 |
| 52 Week Low/High: | $20.39 - $45.39 | Next Earning Date: | 11-06-2025 |
| Revenue: | $723,305,000 | Revenue Growth: | -0.03% |
| Revenue Growth (this year): | 1.35% | Revenue Growth (next year): | 5.10% |
AI-Powered AMPH Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Amphastar Pharmaceuticals Inc. (AMPH)
Director
Avg Cost/Share
$27.10
Shares
4,179
Total Value
$113,253.41
Owned After
35,183
SEC Form 4
Director
Avg Cost/Share
$26.49
Shares
16,679
Total Value
$441,836.72
Owned After
75,531
SEC Form 4
Director
Avg Cost/Share
$25.27
Shares
500
Total Value
$12,633.10
Owned After
75,531
SEC Form 4
Director
Avg Cost/Share
$27.20
Shares
500
Total Value
$13,602.40
Owned After
75,531
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| PRINS RICHARD K | AMPH | Director | Nov 25, 2025 | Sell | $27.10 | 4,179 | $113,253.41 | 35,183 | |
| Petersen Floyd F. | AMPH | Director | Nov 13, 2025 | Sell | $26.49 | 16,679 | $441,836.72 | 75,531 | |
| Petersen Floyd F. | AMPH | Director | Nov 3, 2025 | Sell | $25.27 | 500 | $12,633.10 | 75,531 | |
| Petersen Floyd F. | AMPH | Director | Oct 1, 2025 | Sell | $27.20 | 500 | $13,602.40 | 75,531 |
Compare AMPH vs Leading Stocks
See how AMPH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AMPH Amphastar Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.